SynthesisFrontiers in psychology2026
Exercise as a potent antidepressant intervention in Parkinson's disease: a systematic review and meta-analysis of randomised controlled trials.
Synthesis in Frontiers in psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Among the non-motor symptoms of Parkinson's disease, depression ranks as one of the most common and debilitating, affecting roughly 40% of patients and substantially diminishing quality of life. Pharmacological treatments are often limited by side effects and variable efficacy, highlighting the need for effective non-pharmacological interventions. Although exercise has been proposed as a promising strategy, the optimal exercise prescription parameters for alleviating depressive symptoms in this population remain unclear. Methods: Five databases were searched from inception to December 15, 2025. Randomised controlled trials comparing exercise with non-exercise control groups in adults with Parkinson's disease were included, with the primary outcome being change in depressive symptoms. Results: Twenty-one studies with 24 intervention arms comprising 1,010 participants were included. Exercise significantly reduced depressive symptoms compared with control groups (SMD = -0.93; Conclusion: Exercise significantly alleviates depressive symptoms in people with Parkinson's disease. For people with mild to moderate Parkinson's disease with depression, multicomponent exercise appeared to be the most effective intervention type among those examined; however, aerobic and resistance exercise also significantly improved depressive symptoms. Favorable dosing was observed for sessions of 60 min or longer, program duration exceeding 8 weeks, and a frequency of less than three times per week with total weekly time under 180 min. Importantly, lower doses-including sessions shorter than 60 min, program duration of 8 weeks or less, frequency of three or more times per week, and total weekly time of 180 min or more-also produced significant antidepressant effects, demonstrating the flexibility of exercise prescription for this population. These findings support the incorporation of structured exercise programs into standard care for Parkinson's disease with depressive symptomatology. Clinicians may consider these evidence-based parameters when prescribing exercise to this patient population while recognizing that multiple effective dosing options exist. Systematic review registration: Identifier CRD 420261350303.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.